During the past decade, Matsunami General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Matsunami General Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matsunami General Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Matsunami General Hospital" are "Colorectal Cancer" (2 trials), "Ulcerative Colitis" (2 trials), "Anemia" (1 trials), "Ankylosing Spondylitis" (1 trials) and "End Stage Renal Disease Requiring Hemodialysis" (1 trials). Many other conditions were trialed in "Matsunami General Hospital" in a lesser frequency.

Most popular intervention types in "Matsunami General Hospital" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "UFT adjuvant chemotherapy" (2 trials), "BAY2976217" (1 trials), "Efavaleukin alfa" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.

The vast majority of trials in "Matsunami General Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Matsunami General Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Matsunami General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Matsunami General Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".